FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2908651330> ?p ?o ?g. }

• W2908651330 endingPage "4358" @default.
• W2908651330 startingPage "4345" @default.
• W2908651330 abstract "We recently uncovered a regulatory pathway of the muscle isoform of glycogen phosphorylase (PYGM) that plays an important role in regulating immune function in T cells. Here, using various enzymatic, pulldown, and immunoprecipitation assays, we describe signaling cross-talk between the small GTPases RAS and RAP1A, member of RAS oncogene family (RAP1) in human Kit 225 lymphoid cells, which, in turn, is regulated by the epidermal growth factor receptor (EGFR). We found that this communication bridge is essential for glycogen phosphorylase (PYG) activation through the canonical pathway because this enzyme is inactive in the absence of adenylyl cyclase type 6 (ADCY6). PYG activation required stimulation of both exchange protein directly activated by cAMP 2 (EPAC2) and RAP1 via RAS and ADCY6 phosphorylation, with the latter being mediated by Raf-1 proto-oncogene, Ser/Thr kinase (RAF1). Consistent with this model, PYG activation was EGFR-dependent and may be initiated by the constitutively active form of RAS. Consequently, PYG activation in Kit 225 T cells could be blocked with specific inhibitors of RAS, EPAC, RAP1, RAF1, ADCY6, and cAMP-dependent protein kinase. Our results establish a new paradigm for the mechanism of PYG activation, which depends on the type of receptor involved. We recently uncovered a regulatory pathway of the muscle isoform of glycogen phosphorylase (PYGM) that plays an important role in regulating immune function in T cells. Here, using various enzymatic, pulldown, and immunoprecipitation assays, we describe signaling cross-talk between the small GTPases RAS and RAP1A, member of RAS oncogene family (RAP1) in human Kit 225 lymphoid cells, which, in turn, is regulated by the epidermal growth factor receptor (EGFR). We found that this communication bridge is essential for glycogen phosphorylase (PYG) activation through the canonical pathway because this enzyme is inactive in the absence of adenylyl cyclase type 6 (ADCY6). PYG activation required stimulation of both exchange protein directly activated by cAMP 2 (EPAC2) and RAP1 via RAS and ADCY6 phosphorylation, with the latter being mediated by Raf-1 proto-oncogene, Ser/Thr kinase (RAF1). Consistent with this model, PYG activation was EGFR-dependent and may be initiated by the constitutively active form of RAS. Consequently, PYG activation in Kit 225 T cells could be blocked with specific inhibitors of RAS, EPAC, RAP1, RAF1, ADCY6, and cAMP-dependent protein kinase. Our results establish a new paradigm for the mechanism of PYG activation, which depends on the type of receptor involved." @default.
• W2908651330 created "2019-01-25" @default.
• W2908651330 creator A5010284249 @default.
• W2908651330 creator A5011746260 @default.
• W2908651330 creator A5015776887 @default.
• W2908651330 creator A5065262404 @default.
• W2908651330 creator A5067478190 @default.
• W2908651330 creator A5070457235 @default.
• W2908651330 creator A5082874737 @default.
• W2908651330 creator A5086237262 @default.
• W2908651330 date "2019-03-01" @default.
• W2908651330 modified "2023-10-04" @default.
• W2908651330 title "Epidermal growth factor receptor controls glycogen phosphorylase in T cells through small GTPases of the RAS family" @default.
• W2908651330 cites W1488855661 @default.
• W2908651330 cites W1519246997 @default.
• W2908651330 cites W1595450617 @default.
• W2908651330 cites W1598659248 @default.
• W2908651330 cites W179591200 @default.
• W2908651330 cites W1885709862 @default.
• W2908651330 cites W1913594771 @default.
• W2908651330 cites W1970338715 @default.
• W2908651330 cites W1970694857 @default.
• W2908651330 cites W1973568352 @default.
• W2908651330 cites W1976141600 @default.
• W2908651330 cites W1977660494 @default.
• W2908651330 cites W1982465923 @default.
• W2908651330 cites W1989596020 @default.
• W2908651330 cites W1989917629 @default.
• W2908651330 cites W1992840417 @default.
• W2908651330 cites W1995825598 @default.
• W2908651330 cites W1997210305 @default.
• W2908651330 cites W2000253969 @default.
• W2908651330 cites W2008264147 @default.
• W2908651330 cites W2011033752 @default.
• W2908651330 cites W2014702768 @default.
• W2908651330 cites W2017781661 @default.
• W2908651330 cites W2021164372 @default.
• W2908651330 cites W2029513101 @default.
• W2908651330 cites W2030107946 @default.
• W2908651330 cites W2031126434 @default.
• W2908651330 cites W2031975013 @default.
• W2908651330 cites W2038914606 @default.
• W2908651330 cites W2039805756 @default.
• W2908651330 cites W2040101892 @default.
• W2908651330 cites W2050266770 @default.
• W2908651330 cites W2058988082 @default.
• W2908651330 cites W2070805522 @default.
• W2908651330 cites W2084891440 @default.
• W2908651330 cites W2090514375 @default.
• W2908651330 cites W2096053517 @default.
• W2908651330 cites W2099536948 @default.
• W2908651330 cites W2112078762 @default.
• W2908651330 cites W2126728341 @default.
• W2908651330 cites W2133228280 @default.
• W2908651330 cites W2143563119 @default.
• W2908651330 cites W2147076211 @default.
• W2908651330 cites W2164505583 @default.
• W2908651330 cites W2201021868 @default.
• W2908651330 cites W2319340548 @default.
• W2908651330 cites W2494853255 @default.
• W2908651330 cites W2567682222 @default.
• W2908651330 cites W2603204608 @default.
• W2908651330 cites W2732767128 @default.
• W2908651330 cites W2734414173 @default.
• W2908651330 cites W2766326897 @default.
• W2908651330 cites W4211075026 @default.
• W2908651330 cites W51995314 @default.
• W2908651330 doi "https://doi.org/10.1074/jbc.ra118.005997" @default.
• W2908651330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6433075" @default.
• W2908651330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30647127" @default.
• W2908651330 hasPublicationYear "2019" @default.
• W2908651330 type Work @default.
• W2908651330 sameAs 2908651330 @default.
• W2908651330 citedByCount "12" @default.
• W2908651330 countsByYear W29086513302019 @default.
• W2908651330 countsByYear W29086513302021 @default.
• W2908651330 countsByYear W29086513302022 @default.
• W2908651330 countsByYear W29086513302023 @default.
• W2908651330 crossrefType "journal-article" @default.
• W2908651330 hasAuthorship W2908651330A5010284249 @default.
• W2908651330 hasAuthorship W2908651330A5011746260 @default.
• W2908651330 hasAuthorship W2908651330A5015776887 @default.
• W2908651330 hasAuthorship W2908651330A5065262404 @default.
• W2908651330 hasAuthorship W2908651330A5067478190 @default.
• W2908651330 hasAuthorship W2908651330A5070457235 @default.
• W2908651330 hasAuthorship W2908651330A5082874737 @default.
• W2908651330 hasAuthorship W2908651330A5086237262 @default.
• W2908651330 hasBestOaLocation W29086513301 @default.
• W2908651330 hasConcept C11960822 @default.
• W2908651330 hasConcept C126619667 @default.
• W2908651330 hasConcept C127812441 @default.
• W2908651330 hasConcept C192118531 @default.
• W2908651330 hasConcept C195147555 @default.
• W2908651330 hasConcept C204779464 @default.
• W2908651330 hasConcept C207332259 @default.
• W2908651330 hasConcept C2776179587 @default.
• W2908651330 hasConcept C2777499176 @default.
• W2908651330 hasConcept C2780298669 @default.

• next